🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseNon-invasive MASH biomarkers — March 2026 Page 11

Non-invasive MASH biomarkers — March 2026

AttorneyGrant Thu, Feb 8, 2024 at 1:03 AM 54 replies 3,138 viewsPage 11 of 11
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Feb 6, 2025 at 8:34 PM#51

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Feb 6, 2025 at 9:34 PM
16 14julia.endo, JessicaM_2024, TomFromTexas and 13 others
Reply Quote Save Share Report
JenMemphis
Member
267
1,234
Jan 2025
Memphis, TN
Feb 17, 2025 at 8:03 PM#52
LabKate said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Pushing back on LabKate here. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

17 15BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 14 others
Reply Quote Save Share Report
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Feb 28, 2025 at 7:25 PM#53
LabKate said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.

18 16mona_PHX, andrew_nyc, Dr.EndoEP and 15 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Mar 11, 2025 at 6:41 PM#54
LabKate said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

This is exactly what I could not find anywhere else.

19 17Dr.Martinez, mike_mod, SarahChen_PharmD and 16 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Mar 22, 2025 at 5:51 PM#55

Clinical perspective, offered as context rather than as advice. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

Happy to go further on any of that.

20 18lori_vegas, Dr.PulmRoch, maya_sedona and 17 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register